Last reviewed · How we verify

Maalox plus Benadryl

The University of Texas Health Science Center, Houston · FDA-approved active Small molecule

This combination antacid and antihistamine reduces stomach acid while blocking histamine-mediated gastric secretion and providing anticholinergic effects.

This combination antacid and antihistamine reduces stomach acid while blocking histamine-mediated gastric secretion and providing anticholinergic effects. Used for Heartburn and acid indigestion, Peptic ulcer disease.

At a glance

Generic nameMaalox plus Benadryl
SponsorThe University of Texas Health Science Center, Houston
Drug classAntacid with antihistamine
TargetH1 receptor (diphenhydramine component); direct acid neutralization (antacid component)
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Maalox (aluminum hydroxide and magnesium hydroxide) neutralizes gastric acid through direct chemical reaction, while Benadryl (diphenhydramine) is an H1 receptor antagonist that reduces histamine-mediated acid secretion and provides anticholinergic effects to decrease gastric motility. This combination approach addresses both existing acid and the mechanisms driving acid production.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results